Terms: = Prostate cancer AND BMPR1A, ACVRLK3, 657, ENSG00000107779, P36894, ALK3, CD292 AND Prognosis
8 results:
1. Circulating and Imaging Biomarkers of Radium-223 Response in Metastatic Castration-Resistant prostate cancer.
Saylor PJ; Otani K; Balza R; Ukleja J; Pleskow H; Fisher R; Kusaka E; Otani YS; Badusi PO; Smith MR; Meneely E; Olivier K; Lowe AC; Toner M; Maheswaran S; Haber DA; Yeap BY; Lee RJ; Miyamoto DT
JCO Precis Oncol; 2024 Feb; 8():e2300230. PubMed ID: 38354328
[TBL] [Abstract] [Full Text] [Related]
2. prostate cancer Risk Stratification by Simple Scoring of the Current pT3 Lesions: A Proposal for a New Pathologic T-Staging System.
Miyamoto H; Teramoto Y; Numbere N; Wang Y; Joseph JV
Mod Pathol; 2024 Mar; 37(3):100429. PubMed ID: 38266919
[TBL] [Abstract] [Full Text] [Related]
3. Bilateral Seminal Vesicle Invasion Is Not Associated with Worse Outcomes in Locally Advanced prostate Carcinoma.
Vidal Crespo N; Enguita Arnal L; Gómez-Ferrer Á; Collado Serra A; Mascarós JM; Calatrava Fons A; Casanova Ramón-Borja J; Rubio Briones J; Ramírez-Backhaus M
Medicina (Kaunas); 2022 Aug; 58(8):. PubMed ID: 36013525
[No Abstract] [Full Text] [Related]
4. The Role of Androgen Receptor Splicing Variant 7 in Predicting the prognosis of Metastatic Castration-Resistant prostate cancer: Systematic Review and Meta-Analysis.
Liu RJ; Hu Q; Li SY; Mao WP; Xu B; Chen M
Technol Cancer Res Treat; 2021; 20():15330338211035260. PubMed ID: 34313171
[TBL] [Abstract] [Full Text] [Related]
5. Norms of vagal nerve activity, indexed by Heart Rate Variability, in cancer patients.
De Couck M; Gidron Y
Cancer Epidemiol; 2013 Oct; 37(5):737-41. PubMed ID: 23725879
[TBL] [Abstract] [Full Text] [Related]
6. PTEN genomic deletions that characterize aggressive prostate cancer originate close to segmental duplications.
Yoshimoto M; Ludkovski O; DeGrace D; Williams JL; Evans A; Sircar K; Bismar TA; Nuin P; Squire JA
Genes Chromosomes Cancer; 2012 Feb; 51(2):149-60. PubMed ID: 22045666
[TBL] [Abstract] [Full Text] [Related]
7. [Interferon-producing capacity in patients with prostate cancer: prognosis value].
Kita M; Nakagawa S; Watanabe H; Kitoh I; Yamaji M; Kishida T; Imanishi J
C R Seances Soc Biol Fil; 1990; 184(2):181-6. PubMed ID: 2148903
[TBL] [Abstract] [Full Text] [Related]
8. Serial prostatic histology. A valid marker of response to hormone treatment.
Bishop MC; Ansell ID; Taylor MC; Thomas AL
Br J Urol; 1985 Aug; 57(4):453-7. PubMed ID: 3896369
[TBL] [Abstract] [Full Text] [Related]
